We use cookies to ensure our site functions properly and to store limited information about your usage. You may give or withdraw consent at any time. To find out more, read our privacy policy and cookie policy.
Manage Cookies
A cookie is information stored on your computer by a website you visit. Cookies often store your settings for a website, such as your preferred language or location. This allows the site to present you with information customized to fit your needs. As per the GDPR law, companies need to get your explicit approval to collect your data. Some of these cookies are ‘strictly necessary’ to provide the basic functions of the website and can not be turned off, while others if present, have the option of being turned off. Learn more about our Privacy and Cookie policies. These can be managed also from our cookie policy page.
Strictly necessary cookies(always on):
Necessary for enabling core functionality. The website cannot function properly without these cookies. This cannot be turned off. e.g. Sign in, Language
Analytics cookies:
Analytical cookies help us to analyse user behaviour, mainly to see if the users are able to find and act on things that they are looking for. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. Tools used: Google Analytics
Prevention - All communities enabled to live healthy lifestyles, aware of concerning symptoms and know how to seek appropriate help. .
Improved Access and Earlier Diagnosis - People to have access to a wide range of high quality and timely services (including screening), leading to an earlier diagnosis.
Faster Diagnosis and Sustainable Capacity - Workforce and infrastructure are in place to ensure faster diagnosis.
Patient Focus / Personalised Care - Reduce variation in diagnosis and treatment by ensuring appropriate personalised support.
Innovation - Courageous approach to innovation and research to improve patient quality of life and survival.
How we can work together to know we have made a difference
The difference that we will measure ...
Increase in patients diagnosed at an earlier stage so that 75% of patients will be diagnosed at Stage 1 or 2 by 2028 in line with the National NHS Long Term Plan. In 2019, 57% - 59% of people were diagnosed at Stage 1 or 2 across Suffolk and North Essex.
Increase in 1-year survival to 79% and 5 year survival to 70% in line with the National NHS Long Term Plan by 2028. We will show incremental improvements each year. It is expected that the COVID 19 pandemic will have negatively impacted this. Through the actions described we will show progress to achieve the National target.
Increased responses from across all communities and increased scores for the National Quality of Life (QoL) Survey. The current response rate is 50% on average with a greater proportion of white people responding to the surveys. Through the actions described we will show a greater uptake across all communities and tumour sites to enable this data to drive changes in our services.
Increased National Cancer Patient Experience Survey (CPES) so that meaningful changes to services can be made. We will demonstrate improvements each year until 2028 via annual review.
Closure of the gap between under 75-year cancer mortality in deprived and less deprived communities (reduce the slope index). We will show improvements each year.
Achievement of the national screening targets for breast, colorectal and cervical across all the communities, considering deprivation and addressing pockets of worse performance. We will show incremental improvements each year until 2028.
How we will make a difference
Actions:
Prevention - All communities enabled to live healthy lifestyles, aware of concerning symptoms and know how to seek appropriate help. .
Improved Access and Earlier Diagnosis - People to have access to a wide range of high quality and timely services (including screening), leading to an earlier diagnosis.
Faster Diagnosis and Sustainable Capacity - Workforce and infrastructure are in place to ensure faster diagnosis.
Patient Focus / Personalised Care - Reduce variation in diagnosis and treatment by ensuring appropriate personalised support.
Innovation - Courageous approach to innovation and research to improve patient quality of life and survival.
How we can work together to know we have made a difference
The difference that we will measure ...
Increase in patients diagnosed at an earlier stage so that 75% of patients will be diagnosed at Stage 1 or 2 by 2028 in line with the National NHS Long Term Plan. In 2019, 57% - 59% of people were diagnosed at Stage 1 or 2 across Suffolk and North Essex.
Increase in 1-year survival to 79% and 5 year survival to 70% in line with the National NHS Long Term Plan by 2028. We will show incremental improvements each year. It is expected that the COVID 19 pandemic will have negatively impacted this. Through the actions described we will show progress to achieve the National target.
Increased responses from across all communities and increased scores for the National Quality of Life (QoL) Survey. The current response rate is 50% on average with a greater proportion of white people responding to the surveys. Through the actions described we will show a greater uptake across all communities and tumour sites to enable this data to drive changes in our services.
Increased National Cancer Patient Experience Survey (CPES) so that meaningful changes to services can be made. We will demonstrate improvements each year until 2028 via annual review.
Closure of the gap between under 75-year cancer mortality in deprived and less deprived communities (reduce the slope index). We will show improvements each year.
Achievement of the national screening targets for breast, colorectal and cervical across all the communities, considering deprivation and addressing pockets of worse performance. We will show incremental improvements each year until 2028.
